MJ Unpacked Interviews: Melissa Khan: Ass. Exec. Director: Missouri Cannabis Trade Association
Latest News
Analysis: The DEA Is Now Fighting to Move Cannabis to Schedule III
WASHINGTON, D.C.,- For more than 50 years, the Drug Enforcement Administration has helped enforce federal Cannabis prohibition. This week, the DEA formally argued that Cannabis no longer belongs in Schedule I. In its final written ...
Under Delisting Pressure, IM Cannabis Approves Reverse Stock Split
TORONTO – IM Cannabis Corp. (IMCC), a medical Cannabis company operating in Israel and Germany, announced that its board has approved a one-for-thirty share consolidation, effective August 27, with September 15 as the outside date. ...
Johnson & Johnson Signs On to Lead Delix’s $85M Series C
NEW BRUNSWICK – Johnson & Johnson has agreed to lead a Series C financing for Delix Therapeutics, the biotech developing non-hallucinogenic drugs designed to promote neuroplasticity in patients with serious psychiatric conditions. The round is ...


































